Trade SABSW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
SAB Biotherapeutics, Inc. Warrant (SABSW) is trading at US$0.01, down 7.59% today as of Sep 18, 16:00 EDT. Over the past 52 weeks, SABSW has traded between US$0.00 and US$0.20. On Syfe you can trade SABSW with $0 commission and add it to your watchlist.
| Previous close | US$0.02 |
|---|---|
| 52-week range | US$0.00 – US$0.20 |
| Volume | 3.06K |
| Exchange | US |
Add to Watchlist
Set Price Alert
SAB Biotherapeutics, Inc. Warrant
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. The company was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
Year: 2021
SAB Biotherapeutics, Inc. Warrant (SABSW) stock is trading at US$0.01, -7.59% from the previous close of US$0.02.
The 52-week high for SAB Biotherapeutics, Inc. Warrant (SABSW) stock is US$0.20.
The 52-week low for SAB Biotherapeutics, Inc. Warrant (SABSW) stock is US$0.00.
SAB Biotherapeutics, Inc. Warrant (SABSW) does not currently pay a dividend.
Stay on top of SABSW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
